Takeda Closes In On Shire With Revised £49/Share Offer

25 Apr 2018

Takeda further ups its offer for Shire to around £49 per share, which Shire’s board has said it is willing to recommend to shareholders, although any final deal remains subject to conditions and Takeda investors appear concerned over the size of the transaction.

chart — TAKEDA CLOSES IN ON SHIRE • Source: Shutterstock

Shire PLC has confirmed it has received another revised acquisition proposal from determined suitor Takeda Pharmaceutical Co. Ltd., which ups the Japanese company’s offer from the equivalent of £47 per ordinary share to around £49 per share.

The deal, if agreed, would value Shire – which currently exceeds Takeda's roughly $33bn market capitalization by some $17bn –...